SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001104659-21-052045
Filing Date
2021-04-19
Accepted
2021-04-19 17:20:01
Documents
9
Period of Report
2021-06-16

Document Format Files

Seq Description Document Type Size
1 PRE 14A tm212439-1_pre14a.htm PRE 14A 2611401
2 GRAPHIC lg_anglochinese-bwlr.jpg GRAPHIC 11054
3 GRAPHIC lh_anglochin-bwlr.jpg GRAPHIC 31495
4 GRAPHIC sg_scottasamuels-bw.jpg GRAPHIC 13268
5 GRAPHIC tm212439d1-lc_shareprice4c.jpg GRAPHIC 79305
6 GRAPHIC tm212439d1-proxy_beigpg1bw.jpg GRAPHIC 561915
7 GRAPHIC tm212439d1-proxy_beigpg2bw.jpg GRAPHIC 536994
8 GRAPHIC tm212439d1-proxy_beigpg3bw.jpg GRAPHIC 142280
9 GRAPHIC tm212439d1-txt_beigeneltdbw.jpg GRAPHIC 2273
  Complete submission text file 0001104659-21-052045.txt   4506440
Mailing Address C/O MOURANT GOVERNANCE SERVICES (CAYMAN) 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108
Business Address C/O MOURANT GOVERNANCE SERVICES (CAYMAN) 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108 13459494123
BeiGene, Ltd. (Filer) CIK: 0001651308 (see all company filings)

IRS No.: 981209416 | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-37686 | Film No.: 21835469
SIC: 2834 Pharmaceutical Preparations